Turn Therapeutics is a clinical-stage biotechnology company focused on dermatology, wound care, and infectious disease. They develop first-in-class topical cytokine-modulating therapeutics designed to deliver targeted anti-inflammatory effects without systemic immune exposure or injections.
Bradley Burnam
Founder/CEO Turn Therapeutics
"Want to thank NANOBOT GROUP for delivering game-changing materials ahead of the J.P. Morgan healthcare conference.
I cannot speak highly enough about longtime friend Yuriy Svidinenko or his team. They crunched keyboards through the holidays and remade our website & deck in record time.
If you haven’t seen the new digs, check em’ out! It’s science front and center over here. MOA’s and RCT’s and IL’s...all the acronyms!"